Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
Breast Cancer Research : BCR|July 29, 2025
Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBCNasi Liu, Jurjun J S van der Velde, Sherien Ramdjielal, et al.
Scientific Reports|April 1, 2021
Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapyEsmee Koedoot, Liesanne Wolters, Marcel Smid, et al.
Toxicology|May 7, 2026
Towards a novel toxicity prediction pipeline, combining PBPK models and mechanistic cellular adversity modelsElsje J Burgers, Raju P Sharma, Tamara Y Danilyuk, et al.
Endocrine-Related Cancer|March 16, 2010
Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cellsCarla S Verissimo, Jan J Molenaar, John Meerman, et al.
Plos One|October 3, 2013
Silencing of doublecortin-like (DCL) results in decreased mitochondrial activity and delayed neuroblastoma tumor growthCarla S Verissimo, Rachel Elands, Sou Cheng, et al.
Mutation Research|March 1, 2007
A portrait of cisplatin-induced transcriptional changes in mouse embryonic stem cells reveals a dominant p53-like responseJacqueline J C M Kruse, J Peter Svensson, Merei Huigsloot, et al.
Archives of Toxicology|June 14, 2019
Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicantsJohannes Delp, Melina Funke, Franziska Rudolf, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|August 5, 2025
Distinct lipidomic profiles in breast cancer cell lines relate to proliferation and EMT phenotypesHanneke Leegwater, Zhengzheng Zhang, Xiaobing Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 12, 2012
Combining doublecortin-like kinase silencing and vinca alkaloids results in a synergistic apoptotic effect in neuroblastoma cellsCarla S Verissimo, Sou Cheng, Jordi C Puigvert, et al.
Oncotarget|September 30, 2015
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicinZuzanna Baranski, Yvonne de Jong, Trayana Ilkova, et al.
Pageof 21